Skip to main content
Top

23-04-2024 | Peripheral Arterial Disease | Research article

Efficacy of comprehensive structured exercise program on claudication pain and quality of life in type 2 diabetes mellitus with peripheral arterial disease

Authors: Esha Arora, G. Arun Maiya, Tom Devasia, Ram Bhat, Ganesh Kamath

Published in: Journal of Diabetes & Metabolic Disorders

Login to get access

Abstract

Background

Peripheral arterial disease is one of the leading complications of type 2 diabetes mellitus. The primary symptom of peripheral arterial disease is claudication pain. Exercise is known to improve the claudication pain, thereby improving the quality of life.

Methods

A total of 74 participants were recruited in each group and a detailed demographic assessment was done for all the participants. The study group received a comprehensive structured exercise program and standard care whereas the control group received only the standard care. Progression of the exercise was made at the 6th week of the protocol. All the outcome measures were reassessed after the 12th weeks for both study and control group.

Results

The mean age of participants was 60.78 ± 11.29 (years) and 59.98 ± 11.42 (years) for the study and control group, respectively. There was a statistically significant difference in toe brachial index (p < 0.001), ankle brachial index (p < 0.001), 6-minute walk distance (p < 0.001), WHO-BREF quality of life questionnaire (p < 0.001), and walking ability ((p < 0.001) in the study group in comparison to the control group.

Conclusion

In the present study we found that comprehensive structured exercise program improves the arterial indices, quality of life, walking ability and reduces claudication pain in type 2 diabetes mellitus with peripheral arterial disease.
Appendix
Available only for authorised users
Literature
2.
go back to reference Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, Shaw JE. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas. Diabetes research and clinical practice. 2019;157:107843. Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, Shaw JE. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas. Diabetes research and clinical practice. 2019;157:107843.
3.
go back to reference Criqui MH, Matsushita K, Aboyans V, Hess CN, Hicks CW, Kwan TW, McDermott MM, Misra S, Ujueta F. Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the American Heart Association. Circulation. 2021;144(9):e171–91.CrossRefPubMedPubMedCentral Criqui MH, Matsushita K, Aboyans V, Hess CN, Hicks CW, Kwan TW, McDermott MM, Misra S, Ujueta F. Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the American Heart Association. Circulation. 2021;144(9):e171–91.CrossRefPubMedPubMedCentral
4.
go back to reference Kim MS, Hwang J, Yon DK, Lee SW, Jung SY, Park S, Johnson CO, Stark BA, Razo C, Abbasian M, Abbastabar H. Global burden of peripheral artery disease and its risk factors, 1990–2019: a systematic analysis for the global burden of Disease Study 2019. Lancet Global Health. 2023;11(10):e1553–65.CrossRef Kim MS, Hwang J, Yon DK, Lee SW, Jung SY, Park S, Johnson CO, Stark BA, Razo C, Abbasian M, Abbastabar H. Global burden of peripheral artery disease and its risk factors, 1990–2019: a systematic analysis for the global burden of Disease Study 2019. Lancet Global Health. 2023;11(10):e1553–65.CrossRef
5.
go back to reference Khanna NN, Krishna V, Manjunath CN, Tyagi S, Jindal R, Chadha M, Natesh BH, Warawdekar G, Wangnoo SK, Chopra HK, Jagia P. The Indian Consensus Statement for the management of Lower Extremity Peripheral Artery Disease. J Indian Coll Cardiol. 2023;13(Special Suppl 1):S1–20.CrossRef Khanna NN, Krishna V, Manjunath CN, Tyagi S, Jindal R, Chadha M, Natesh BH, Warawdekar G, Wangnoo SK, Chopra HK, Jagia P. The Indian Consensus Statement for the management of Lower Extremity Peripheral Artery Disease. J Indian Coll Cardiol. 2023;13(Special Suppl 1):S1–20.CrossRef
6.
go back to reference Makkar BM, Sharma JK, Jaggi S, SOOTA K, Gupta V. KHURANA G. Low prevalence of peripheral arterial disease in type 2 diabetes patients in North India. Diabetes. 2018;67(Supplement_1). Makkar BM, Sharma JK, Jaggi S, SOOTA K, Gupta V. KHURANA G. Low prevalence of peripheral arterial disease in type 2 diabetes patients in North India. Diabetes. 2018;67(Supplement_1).
7.
go back to reference Singh SP. Prevalence of peripheral artery disease in uncontrolled diabetic patients by using ankle brachial pressure index as a routine procedure. Int J Res Rev. 2020;7(9):238–41. Singh SP. Prevalence of peripheral artery disease in uncontrolled diabetic patients by using ankle brachial pressure index as a routine procedure. Int J Res Rev. 2020;7(9):238–41.
8.
go back to reference Treat-Jacobson D, McDermott MM, Bronas UG, Campia U, Collins TC, Criqui MH, Gardner AW, Hiatt WR, Regensteiner JG, Rich K, American Heart Association Council on Peripheral Vascular Disease; Council on Quality of Care and Outcomes Research; and Council on Cardiovascular and Stroke Nursing. Optimal exercise programs for patients with peripheral artery disease: a scientific statement from the American Heart Association. Circulation. 2019;139(4):e10–33.CrossRefPubMed Treat-Jacobson D, McDermott MM, Bronas UG, Campia U, Collins TC, Criqui MH, Gardner AW, Hiatt WR, Regensteiner JG, Rich K, American Heart Association Council on Peripheral Vascular Disease; Council on Quality of Care and Outcomes Research; and Council on Cardiovascular and Stroke Nursing. Optimal exercise programs for patients with peripheral artery disease: a scientific statement from the American Heart Association. Circulation. 2019;139(4):e10–33.CrossRefPubMed
9.
go back to reference Khoury SR, Ratchford EV, Stewart KJ. Supervised exercise therapy for patients with peripheral artery disease: clinical update and pathways forward. Prog Cardiovasc Dis. 2022;70:183–9.CrossRefPubMed Khoury SR, Ratchford EV, Stewart KJ. Supervised exercise therapy for patients with peripheral artery disease: clinical update and pathways forward. Prog Cardiovasc Dis. 2022;70:183–9.CrossRefPubMed
10.
go back to reference Kanaley JA, Colberg SR, Corcoran MH, Malin SK, Rodriguez NR, Crespo CJ, Kirwan JP, Zierath JR. Exercise/physical activity in individuals with type 2 diabetes: a consensus statement from the American College of Sports Medicine. Medicine and science in sports and exercise. 2022. Kanaley JA, Colberg SR, Corcoran MH, Malin SK, Rodriguez NR, Crespo CJ, Kirwan JP, Zierath JR. Exercise/physical activity in individuals with type 2 diabetes: a consensus statement from the American College of Sports Medicine. Medicine and science in sports and exercise. 2022.
11.
go back to reference American Thoracic Society. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111–7.CrossRef American Thoracic Society. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111–7.CrossRef
12.
go back to reference WHOQOL Group. Development of the WHOQOL: Rationale and current status. Int J Mental Health. 1994;23:24–56.CrossRef WHOQOL Group. Development of the WHOQOL: Rationale and current status. Int J Mental Health. 1994;23:24–56.CrossRef
13.
go back to reference Nicolaï SP, Kruidenier LM, Rouwet EV, Graffius K, Prins MH, Teijink JA. The walking impairment questionnaire: an effective tool to assess the effect of treatment in patients with intermittent claudication. J Vasc Surg. 2009;50(1):89–94.CrossRefPubMed Nicolaï SP, Kruidenier LM, Rouwet EV, Graffius K, Prins MH, Teijink JA. The walking impairment questionnaire: an effective tool to assess the effect of treatment in patients with intermittent claudication. J Vasc Surg. 2009;50(1):89–94.CrossRefPubMed
14.
go back to reference Hallak AO, Hallak FZ, Hallak YO, Hallak OO, Hayson AW, Tanami SA, Bennett WL, Lavie CJ. Exercise therapy in the management of peripheral arterial disease. Mayo Clinic Proceedings: Innovations, Quality & Outcomes. 2023;7(5):476– 89. Hallak AO, Hallak FZ, Hallak YO, Hallak OO, Hayson AW, Tanami SA, Bennett WL, Lavie CJ. Exercise therapy in the management of peripheral arterial disease. Mayo Clinic Proceedings: Innovations, Quality & Outcomes. 2023;7(5):476– 89.
16.
go back to reference Castro-Sánchez AM, Matarán-Peñarrocha GA, Feriche-Fernández-Castanys B, Fernández-Sola C, Sánchez-Labraca N, Moreno-Lorenzo C. A program of 3 physical therapy modalities improves peripheral arterial disease in diabetes type 2 patients: a randomized controlled trial. J Cardiovasc Nurs. 2013;28(1):74–82.CrossRefPubMed Castro-Sánchez AM, Matarán-Peñarrocha GA, Feriche-Fernández-Castanys B, Fernández-Sola C, Sánchez-Labraca N, Moreno-Lorenzo C. A program of 3 physical therapy modalities improves peripheral arterial disease in diabetes type 2 patients: a randomized controlled trial. J Cardiovasc Nurs. 2013;28(1):74–82.CrossRefPubMed
17.
go back to reference Tehan PE, Sadler SG, Lanting SM, Chuter VH. How does a short period of exercise effect toe pressures and toe-brachial indices? A cross-sectional exploratory study. J Foot Ankle Res. 2018;11(1):1–8.CrossRef Tehan PE, Sadler SG, Lanting SM, Chuter VH. How does a short period of exercise effect toe pressures and toe-brachial indices? A cross-sectional exploratory study. J Foot Ankle Res. 2018;11(1):1–8.CrossRef
18.
go back to reference Treat-Jacobson D, McDermott MM, Bronas UG, Campia U, Collins TC, Criqui MH, Gardner AW, Hiatt WR, Regensteiner JG, Rich K, and American Heart Association Council on Peripheral Vascular Disease.; Council on Quality of CareOutcomes Research;Council on CardiovascularStroke Nursing, 2019. Optimal exercise programs for patients with peripheral artery disease: a scientific statement from the American Heart Association. Circulation, 139(4), pp.e10-e33. Treat-Jacobson D, McDermott MM, Bronas UG, Campia U, Collins TC, Criqui MH, Gardner AW, Hiatt WR, Regensteiner JG, Rich K, and American Heart Association Council on Peripheral Vascular Disease.; Council on Quality of CareOutcomes Research;Council on CardiovascularStroke Nursing, 2019. Optimal exercise programs for patients with peripheral artery disease: a scientific statement from the American Heart Association. Circulation, 139(4), pp.e10-e33.
19.
go back to reference McDermott MM, Liu K, Guralnik JM, Criqui MH, Spring B, Tian L, Domanchuk K, Ferrucci L, Lloyd-Jones D, Kibbe M, Tao H. Home-based walking exercise intervention in peripheral artery disease: a randomized clinical trial. JAMA. 2013;310(1):57–65.CrossRefPubMedPubMedCentral McDermott MM, Liu K, Guralnik JM, Criqui MH, Spring B, Tian L, Domanchuk K, Ferrucci L, Lloyd-Jones D, Kibbe M, Tao H. Home-based walking exercise intervention in peripheral artery disease: a randomized clinical trial. JAMA. 2013;310(1):57–65.CrossRefPubMedPubMedCentral
20.
go back to reference Hap K, Biernat K, Konieczny G. Patients with diabetes complicated by peripheral artery disease: the current state of knowledge on physiotherapy interventions. Journal of Diabetes Research. 2021;2021. Hap K, Biernat K, Konieczny G. Patients with diabetes complicated by peripheral artery disease: the current state of knowledge on physiotherapy interventions. Journal of Diabetes Research. 2021;2021.
21.
go back to reference Alahdab F, Wang AT, Elraiyah TA, Malgor RD, Rizvi AZ, Lane MA, Prokop LJ, Montori VM, Conte MS, Murad MH. A systematic review for the screening for peripheral arterial disease in asymptomatic patients. J Vasc Surg. 2015;61(3):S42–53.CrossRef Alahdab F, Wang AT, Elraiyah TA, Malgor RD, Rizvi AZ, Lane MA, Prokop LJ, Montori VM, Conte MS, Murad MH. A systematic review for the screening for peripheral arterial disease in asymptomatic patients. J Vasc Surg. 2015;61(3):S42–53.CrossRef
22.
go back to reference Bearne L, Holmes MG, Bieles J, Eddy S, Fisher G, Modarai B, Patel S, Peacock JL, Sackley C, Volkmer B, Weinman J. Motivating structured walking activity in people with intermittent claudication (MOSAIC): protocol for a randomised controlled trial of a physiotherapist-led, behavioural change intervention versus usual care in adults with intermittent claudication. BMJ open. 2019;9(8):e030002.CrossRefPubMedPubMedCentral Bearne L, Holmes MG, Bieles J, Eddy S, Fisher G, Modarai B, Patel S, Peacock JL, Sackley C, Volkmer B, Weinman J. Motivating structured walking activity in people with intermittent claudication (MOSAIC): protocol for a randomised controlled trial of a physiotherapist-led, behavioural change intervention versus usual care in adults with intermittent claudication. BMJ open. 2019;9(8):e030002.CrossRefPubMedPubMedCentral
24.
go back to reference Schieber MN, Pipinos II, Johanning JM, Casale GP, Williams MA, DeSpiegelaere HK, Senderling B, Myers SA. Supervised walking exercise therapy improves gait biomechanics in patients with peripheral artery disease. J Vasc Surg. 2020;71(2):575–83.CrossRefPubMed Schieber MN, Pipinos II, Johanning JM, Casale GP, Williams MA, DeSpiegelaere HK, Senderling B, Myers SA. Supervised walking exercise therapy improves gait biomechanics in patients with peripheral artery disease. J Vasc Surg. 2020;71(2):575–83.CrossRefPubMed
25.
go back to reference Lozano FS, González-Porras JR, March JR, Lobos JM, Carrasco E, Ros E. Diabetes mellitus and intermittent claudication: a cross-sectional study of 920 claudicants. Diabetol Metab Syndr. 2014;6(1):21.CrossRefPubMedPubMedCentral Lozano FS, González-Porras JR, March JR, Lobos JM, Carrasco E, Ros E. Diabetes mellitus and intermittent claudication: a cross-sectional study of 920 claudicants. Diabetol Metab Syndr. 2014;6(1):21.CrossRefPubMedPubMedCentral
Metadata
Title
Efficacy of comprehensive structured exercise program on claudication pain and quality of life in type 2 diabetes mellitus with peripheral arterial disease
Authors
Esha Arora
G. Arun Maiya
Tom Devasia
Ram Bhat
Ganesh Kamath
Publication date
23-04-2024
Publisher
Springer International Publishing
Published in
Journal of Diabetes & Metabolic Disorders
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-024-01426-2
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.